3628 results for «31»
3628 results
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Management of non-culprit lesions in patients with ACS and multivessel disease
21 May 2025 – From EuroPCR 2025
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...
Metalfree PCI
21 May 2025 – From EuroPCR 2025
Explore metal-free PCI approaches emphasizing drug-coated balloon angioplasty and bioresorbable scaffold technologies. This session reviews angiographic outcomes in diffuse small vessel disease, bifurcation lesions, and acute myocardial infarction, alongside management strategies for restenosis post-DCB angioplasty, highlighting advancements in minimally invasive coronary interventions.
CTO, modern challenges and solutions
21 May 2025 – From EuroPCR 2025
Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.
Overcoming resistant lesions in NSTEMI
21 May 2025 – From EuroPCR 2025
Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.
New evidence in the PFO closure
21 May 2025 – From EuroPCR 2025
Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.
TAV-in-TAV in SAV 3 valves procedures
21 May 2025 – From EuroPCR 2025
Examine the complexities of TAV-in-TAV procedures in degenerated surgical aortic valves (SAV) and TAVI valves. This session discusses cases involving massive aortic regurgitation, lifetime management challenges, and valve-in-valve-in-valve scenarios, providing practical insights into managing multiple valve interventions and associated complications.
LAA closure and anthrombotic therapies
21 May 2025 – From EuroPCR 2025
Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.
Coils and plugs for coronary intervention
21 May 2025 – From EuroPCR 2025
This session highlights the use of coils and plugs in complex coronary interventions. Through unique case presentations, it covers diagnosis and management of unusual cardiac masses, recurrent fistulas, and rare causes of angina, illustrating innovative device applications in challenging coronary anatomy and post-surgical scenarios.
Coronary scaffolds: new developments and applications
21 May 2025 – From EuroPCR 2025
Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.
Complex multivessel disease - LIVE Case
21 May 2025 – From EuroPCR 2025
An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...
Which valve is best for my patient?
21 May 2025 – From EuroPCR 2025
This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.
Current DCB practice: from lesion preparation to follow-up
21 May 2025 – From EuroPCR 2025
Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
How are we going to treat these sick patients presenting with pulmonary embolism?
21 May 2025 – From EuroPCR 2025
Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.
TAVI in challenging anatomical situations
21 May 2025 – From EuroPCR 2025
Delve into the latest advancements in TAVI for challenging anatomical situations. This session features insights from the NORTHOSTAVI registry, transcaval TAVI experiences, early discharge protocols following alternative access, and the application of intravascular lithotripsy to enable safe transfemoral valve replacement.
Critical limb ischaemia below the knee treatment
21 May 2025 – From EuroPCR 2025
This session focuses on advanced techniques for treating critical limb ischaemia below the knee. Understand how to select wires for antegrade recanalisation, the role and timing of retrograde access, and the potential benefits of drug-coated balloons in below-the-knee angioplasty.
Transcatheter tricuspid valve replacement in the real world: current data and outcomes
21 May 2025 – From EuroPCR 2025
Explore current real-world data and outcomes of transcatheter tricuspid valve replacement (TTVR). This session reviews UK single-centre experiences, registry data, long-term right ventricular remodeling effects, safety in pacemaker patients, and AI-based CT screening for patient selection.
Enhancing knowledge in diagnosis ANOCA
21 May 2025 – From EuroPCR 2025
Enhance your understanding of the diagnosis of ANOCA through advanced diagnostic techniques. Topics include coronary endothelial function assessment, exercise stress testing for microvascular dysfunction, acetylcholine-induced coronary responses, and the clinical implications of myocardial bridge in provocative testing.
